The University of Cincinnati researchers win NCI grant to study combination colorectal cancer treatment

Shutdown precluded NCI officials from appearing at AACI/CCAF annual meeting

NCI officials were notably absent from the annual meeting of the Association of American Cancer Institutes and the Cancer Center Administrators Forum in Washington, DC, due to the government shutdown that started on Oct. 1.

Zanzalintinib + atezolizumab improve survival in advanced CRC

Combining zanzalintinib, a targeted therapy drug, and atezolizumab, an immune checkpoint inhibitor, helped patients with metastatic colorectal cancer live longer and control their disease better than with the standard treatment drug regorafenib, according to a study led by UCLA investigators.

October 24, 2025

Vol.51 No.39

Guest Editorial

Study finds no correlation between cancer burden in catchment areas and cancer centers’ CCSG funding

When the idea of looking at cancer center funding and the cancer burden of cancer center catchment areas came to us in the summer of 2024, we lived in a different context.

October 17, 2025

Vol.51 No.38

By Todd Burus, Caree McAfee and Pamela C. Hull

Clinical Roundup

Researchers identify two groups of antigen-presenting fibroblasts that support survival and growth of malignant tumors

UT Southwestern Medical Center researchers have identified two distinct populations of cells known as antigen-presenting cancer-associated fibroblasts that appear to support the survival and growth of malignant tumors.

October 10, 2025

Vol.51 No.37

NCI

Anthony Letai sworn in as 18th NCI director

Anthony G. Letai, accompanied by his wife Jean, was sworn in by HHS Secretary Kennedy as the 18th NCI Director on Sept. 29.Anthony G. Letai, a physician-scientist at Harvard Medical School and Dana-Farber Cancer Institute, has been officially named the 18th director of the National Cancer Institute.

October 03, 2025

Vol.51 No.36

By Claire Marie Porter

Capitol Hill

U.S. government shuts down
Impact on NCI uncertain as administration threatens more RIFs

On Oct. 1, for the first time in six years, the U.S. government shut down after Congress was unable to reach a deal to fund federal agencies for Fiscal Year 2026.

October 03, 2025

Vol.51 No.36

By Claire Marie Porter

The University of Cincinnati researchers win NCI grant to study combination colorectal cancer treatment

YOU MAY BE INTERESTED IN

Shutdown precluded NCI officials from appearing at AACI/CCAF annual meeting

Zanzalintinib + atezolizumab improve survival in advanced CRC

Study finds no correlation between cancer burden in catchment areas and cancer centers’ CCSG funding

Researchers identify two groups of antigen-presenting fibroblasts that support survival and growth of malignant tumors

Anthony Letai sworn in as 18th NCI director

U.S. government shuts down
Impact on NCI uncertain as administration threatens more RIFs

Renew today!

Subscriber content

Never miss an issue!

Login

The University of Cincinnati researchers win NCI grant to study combination colorectal cancer treatment

YOU MAY BE INTERESTED IN

Shutdown precluded NCI officials from appearing at AACI/CCAF annual meeting

Zanzalintinib + atezolizumab improve survival in advanced CRC

Study finds no correlation between cancer burden in catchment areas and cancer centers’ CCSG funding

Researchers identify two groups of antigen-presenting fibroblasts that support survival and growth of malignant tumors

Anthony Letai sworn in as 18th NCI director

U.S. government shuts downImpact on NCI uncertain as administration threatens more RIFs

Never miss an issue!

Login

U.S. government shuts down
Impact on NCI uncertain as administration threatens more RIFs